The daily sleep/wakefulness cycle is regulated by coordinated interactions between 2 sleep-and wakefulness-regulating neural circuitry. However, the detailed neural circuitry 3 mediating sleep is far from understood. Here, we found that glutamic acid 4 decarboxylase 67 (Gad67)-positive GABAergic neurons in the ventral tegmental area 5 (VTAGad67+) are a key regulator of non-rapid eye movement (NREM) sleep in mice. 6 VTAGad67+ neurons project to multiple brain areas implicated in sleep/wakefulness 7 regulation such as the lateral hypothalamus (LH) and dorsal raphe nucleus.
dorsal raphe nucleus (DR), and pontine reticular nucleus (PnO). These brain areas are 23 also reported to be involved in the modulation of the sleep/wakefulness, suggesting that 24 VTAGad67+ neurons might play a role in this regulation (Brown et al., 2012) . . We then confirmed the function of hM3Dq by applying its 1 ligand clozapine-N-oxide (CNO) to acute brain slices while recording neuronal activity 2 (Supplemental Figure 1c ). As expected, CNO application significantly increased the 3 firing frequency of hM3Dq-expressing, but not mCherry-expressing, VTAGad67+ neurons 4 (Supplemental Figure 1d -e, hM3Dq: 286 ± 61%, n = 8 cells; mCherry: 110 ± 8%, n = 6 5 cells, p = 0.02, unpaired t-test). Next, to analyze the effect of CNO-induced activation of 6 VTAGad67+ neurons in sleep/wakefulness states, electroencephalogram (EEG) and 7 electromyogram (EMG) electrodes were implanted in Gad67-Cre mice (Figure 2a ). After 8 recovery from the surgery and behavioral habituation (see methods), either saline or 9 CNO (1 mg/kg) were administered intraperitoneally (i.p.) just before the onset of the Since activation of VTAGad67+ neurons resulted in increases in NREM sleep with 27 increases in delta wave power, we next examined the selective inhibition of VTAGad67+ 28 neurons, which might be expected to increase wakefulness. To test this, we used an 29 acute inhibition strategy with optogenetics. An inhibitory anion channel, (Mohammad et al., 2017) . We first confirmed the function 32 of ACR2 employing in vitro electrophysiology. Three weeks after injection of AAV 7 (expressing either ACR2-2A-mCherry or mCherry) into the VTA of Gad67-Cre mice, we 1 prepared acute brain slices including the VTA and performed cell-attached recordings 2 from mCherry-expressing neurons. Blue light (6.8 mW/mm 2 ) was able to completely 3 silence the spontaneous activity of ACR2-2A-mCherry-expressing VTAGad67+ neurons (n 4 = 10 cells), whereas light irradiation on mCherry alone-expressing neurons had no such 5 effect (n = 7 cells) ( Supplementary Figure 2d -f). Next, using these two groups of mice, 6 we implanted fiber optics at a diameter of 400 µm into the VTA along with EEG and 7 EMG recordings (Figure 3a and 3b). After recovery and habituation, continuous blue 8 light for 5 sec was illuminated every 15 min for 24 hr (Figure 3c ). Interestingly, blue light 9 illumination immediately induced wakefulness from NREM sleep, but not from REM 21 p = 0.02, unpaired t-test). Again, REM sleep was not affected. Therefore, these data 22 showed that in vivo optogenetic inhibition of VTAGad67+ neurons promoted and sustained 23 wakefulness in mice. This result clearly suggested that VTAGad67+ neurons have a role in 24 the regulation of not only NREM sleep but also wakefulness.
25
Next, we tested whether brief (5 sec) optogenetic inhibition of VTAGad67+ 26 neurons can induce arousal even under conditions of high homeostatic sleep pressure.
27
To test this, mice were sleep deprived for 4 hr, starting at light onset, and were then 28 allowed to experience recovery sleep for 30 min (Figure 4a ). Sleep-deprived animals 29 usually display extended NREM sleep because of high homeostatic sleep pressure.
30
Moreover, the slow-wave activity in NREM sleep increases during recovery sleep 31 (Lancel et al., 1992) . However, to our surprise, even under such a higher sleep pressure Figure 3f ). Notably, VTAGad67+ neurons 27 began to increase their activity before wake-to-NREM transitions (mean ΔF/F: Wake: 28 2.9 ± 0.4%, NREM: 3.8 ± 0.4%, p = 2.5e-6) and decrease their activity before 29 NREM-to-REM (mean ΔF/F: NREM: 5.0 ± 0.5%, REM: 2.7 ± 0.3%, p = 2.4e-5) and 30 NREM-to-wake (mean ΔF/F: NREM: 3.8 ± 0.5%, wake: 3.0 ± 0.4%, p = 2.4e-4) 31 transitions. However, the changes in signal from REM-to-wake (mean ΔF/F: REM: 2.9 ± 32 0.4%, wake: 3.7 ± 0.5%, p = 0.02) was comparatively less significant and occurred only 9 after the onset of state transition. Most interestingly, the population activity of VTAGad67+ 1 neurons was found to be completely contrary to DA neuronal activity in the VTA (Dahan 
29
To reveal the mechanism of inhibition of orexin neurons, we performed 
19
However, not much scientific literature has been published focusing on the functional 20 importance of GABAergic neurons in the VTA. Therefore, our findings on the role of 21 these neurons in sleep/wakefulness regulation will provide a conceptual and systematic 22 framework for the association between sleep and psychiatric disorders and will 23 generate opportunities to study VTA-related dysregulation in mental disorders. 
30
We now argue that one reason for such disruption in behavior might be promotion of 31 NREM sleep by selective activation of GABAergic neurons in the VTA.
32
Using bidirectional chemogenetic manipulations as well as neurotoxic lesions we report that VTAGad67+ neurons project to those areas, suggesting the existence of a 1 mutual interaction with these brain areas to regulate sleep/wakefulness.
2
In conclusion, our study elucidated that VTAGABA neurons regulate NREM Nagoya University, Japan. All efforts were made to reduce the number of animals used 5 and also to minimize the suffering and pain of animals. Animals were maintained on a 6 12-hour light-dark cycle (lights were turned on at 8:00 am), with free access to food and 7 water.
9
Generation and Microinjection of Adeno-Associated Virus (AAV) Vectors 10 AAV vectors were produced using the AAV Helper-Free System (Agilent Technologies,
11
Inc., Santa Clara, CA). The virus purification method was adopted from a previously 
19
Germany) at 37°C for 30 min, and were centrifuged 2 times at 16,000 g for 10 min at 20 4°C. The supernatant was used as the virus-containing solution. Quantitative PCR was 21 performed to measure the titer of purified virus. Virus aliquots were then stored at -80°C 22 until use.
23
Adult Gad67-Cre or orexin-Flp; Gad67-Cre mice of both sexes were subjected 24 to either unilateral or bilateral injection of AAV(9)-CMV-FLEX-hrGFP (100 X1 nl, 25 6.0×10 12 copies/ml), AAV(9)-CAG-FLEX-hM3Dq-mCherry (200 X2 nl, 1.1×10 12 26 copies/ml), AAV(9)-CMV-FLEX-ACR2-2A-mCherry (300 X2 nl, 6.2×10 12 copies/ml),
27
AAV(9)-CAG-FLEX-mCherry (300 X2 nl, 1.9×10 12 copies/ml), AAV(9)-CMV-FLEX-ChR2
28
(ET/TC)-eYFP (300 nl, 3.0×10 13 copies/ml), or AAV(9)-CMV-FLEX-GCaMP6f (300 X1 nl, 
37
Immunohistochemistry 38 Under deep anesthesia with 0.65% pentobarbital sodium solution (Kyoritsu Seiyaku
39
Corporation, Tokyo, Japan) diluted with saline (1.0 ml/kg body weight), mice were 40 subjected to serial transcardial perfusion first using ice-cold saline (20 ml) and then ice-cold 4% formaldehyde solution (20 ml, Fujifilm Wako Pure Chemical Industries, Ltd.,
1
Osaka, Japan). The brain was then gently collected and post-fixed with 4% 2 formaldehyde solution at 4°C overnight. Later, the brain was subsequently immersed in 3 phosphate-buffered saline (PBS) containing 30% sucrose at 4°C for at least 2 days.
4
Coronal sections of either 40 or 80 μm thickness were made using a cryostat (Leica 5 CM3050 S; Leica Microsystems, Wetzlar, Germany; or Leica VT1000 S, Wetzlar,
6
Germany), and slices were preserved in PBS containing 0.02% of NaN3 at 4°C until 7 stained. For staining, coronal brain sections were immersed in blocking buffer (1% BSA 8 and 0.25% Triton-X in PBS), and then incubated with primary antibodies (TH: Millipore, 
20
Keyence, Osaka, Japan or IX71, Olympus, Tokyo, Japan).
22
Anterograde Tracing and Localization of Brain-Wide Neural Projections
23
A Cre-inducible AAV carrying the hrGFP gene (AAV(9)-CMV-FLEX-hrGFP; 100 X1 nl, 24 6.0×10 12 copies/ml) was unilaterally injected into the VTA of Gad67-Cre mice. Three 25 weeks post-injection, animals were perfused-fixed and brain slices of 80 μm thickness 26 were made serially from the anterior to the posterior part of the brain using a vibratome 27 (Leica VT1000 S, Wetzlar, Germany). After DAPI staining, slices were serially mounted 28 and images were taken using an epifluorescence microscope (BZ-9000, Keyence,
29
Osaka, Japan or IX71, Olympus, Tokyo, Japan). Images were taken using an identical 30 configuration in the microscope and were then analyzed using ImageJ (US National also implanted with the EEG-EMG electrodes following the protocol described above. 
31
In Vivo Recordings and Data Analysis of Neuronal Activity Using Fiber Photometry
32
In vivo population activity of the VTAGad67+ neurons was recorded using a silica fiber of 33 400 μm by implanting the fiber just above the VTA. Details of the fiber photometric 34 recordings are described elsewhere (Inutsuka et al., 2016) . Briefly, the fiber photometry 
7
After recording and sleep analysis, the fiber photometry signal was outputted 8 along with the EEG and EMG signals as a text file of raw data. For each experiment, the 9 photometry signals at all data points were motion averaged and were then converted to 10 ΔF/F by ΔF/F(t) = (F(t)-Fmin)/Fmin. We recorded the signals in the light period as 11 nocturnal animal mice usually show multiple transitions among different vigilance states 12 during the light period. All mice were subjected to at least two recording sessions with at 13 least a 2-day interval in between each session to allow photobleaching recovery. We 14 separated all sleep-state transitions that last at least for 1 min before and after the state 15 change. All the sessions were selected after the photometry signal became stable, as
16
we observed a decay of photometry signal at the beginning of the recordings.
18
Acute Brain Slice Preparation
19
Preparation of acute brain slices and subsequent electrophysiological recordings were 20 performed as previously reported with a slight modification (Chowdhury and Yamanaka, 
27
Germany) and were temporarily placed in an incubation chamber containing a bath 28 solution (in mM: 124 NaCl, 3 KCl, 2 MgCl2, 2 CaCl2, 1.23 NaH2PO4, 26 NaHCO3 and 25 29 glucose) gassed with 95% O2 and 5% CO2 in a 35°C water bath for 30-60 min. Slices
30
were then incubated at room temperature in the same incubation chamber for another 31 30-60 min for recovery.
33
In Vitro Electrophysiology
34
After the recovery period, acute brain slices were transferred to a recording chamber 
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